On one level, the frustrations of the European cannabidiol (CBD) supplements sector are no different from those of many other ingredient categories where health claims cannot be communicated to consumers or Novel Food regulation stands in the way of market development.
But industry impatience seems particularly intense given that the very complexity of the hemp plant and its compounds which makes it apparently so difficult to regulate at the level of the Single Market is, arguably, just what gives it so many health-and-wellness benefits.
This free report explores the CBD space providing insights around market opportunities and challenges. Download now to discover more about:
- Market higher- and lower-growth
- Consumer views
- Regulations and considerations
- PEA: CBD alternative
- Science implications
- Market forecasts
Brought to you by: